Protect Drug Innovation Act
- Last Action
- 6/22/2023
Actions
- 2023-06-22Read twice and referred to the Committee on Finance.
- 2023-06-22Introduced in Senate
CRS Summary
As of 2023-06-22 (00)
Protect Drug Innovation Act
This bill repeals several programs and requirements that were enacted under the Inflation Reduction Act of 2022 relating to the prices of prescription drugs, including (1) the Medicare Drug Price Negotiation Program, (2) provisions that require drug manufacturers to issue rebates for certain drugs under Medicare for which prices increase faster than inflation, and (3) provisions that cap annual out-of-pocket spending under the Medicare prescription drug benefit.
Cosponsors (1)
- Marco Rubio (R-FL)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.